SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056989
Filing Date
2021-11-15
Accepted
2021-11-15 16:01:30
Documents
64
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q idya-10q_20210930.htm   iXBRL 10-Q 3172332
2 EX-10.1 idya-ex101_117.htm EX-10.1 43686
3 EX-10.2 idya-ex102_169.htm EX-10.2 146646
4 EX-31.1 idya-ex311_8.htm EX-31.1 18313
5 EX-31.2 idya-ex312_7.htm EX-31.2 18370
6 EX-32.1 idya-ex321_6.htm EX-32.1 12439
  Complete submission text file 0001564590-21-056989.txt   9299193

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA idya-20210930.xsd EX-101.SCH 50566
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE idya-20210930_cal.xml EX-101.CAL 43357
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE idya-20210930_def.xml EX-101.DEF 172321
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE idya-20210930_lab.xml EX-101.LAB 413369
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idya-20210930_pre.xml EX-101.PRE 312598
12 EXTRACTED XBRL INSTANCE DOCUMENT idya-10q_20210930_htm.xml XML 1525546
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38915 | Film No.: 211410107
SIC: 2834 Pharmaceutical Preparations